Advanced Search
Your search returned 164 results
  • Sep 16, 2014
    New Data from the OpT2mise Efficacy Study to be Presented at EASD Annual Meeting

    VIENNA - September 16, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that new results from the OpT2mise trial are being presented at the European Association for the Study of Diabetes (EASD) 50th

  • Aug 26, 2014
    Sapiens' Deep Brain Stimulation Technologies Strengthen Medtronic's Neuromodulation Portfolio and Neuroscience Leadership Position

    MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep...

  • Aug 20, 2014
    Facility offers educational resources, research capabilities

    SÃO PAULO--(BUSINESS WIRE)--Aug. 20, 2014-- Covidien plc (NYSE: COV) today officially opened its Covidien Center of Innovation Brazil (CCI Brazil), further expanding its educational and research...

  • Aug 1, 2014
    System Offers Innovative Technology for Sinus Surgery. Chronic Sinusitis Affects Nearly 29 Million US Adults

    MINNEAPOLIS - August 1, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the launch of the NuVent(TM) EM Sinus Dilation System for the Fusion® ENT Navigation System, developed and manufactured...

  • Jul 25, 2014
    Net sales up 4%; Medical Devices sales up 5%

    DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 25, 2014-- Covidien plc (NYSE: COV) today announced financial results for the third quarter of fiscal 2014. Third-quarter net sales of $2.69 billion...

Show 5102550100 per page